Your browser doesn't support javascript.
loading
ERBB2 as a prognostic biomarker correlates with immune infiltrates in papillary thyroid cancer.
Jin, Yuchen; Qiu, Xian; He, Ziyan; Wang, JunYao; Sa, Ri; Chen, Libo.
Affiliation
  • Jin Y; Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.
  • Qiu X; Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.
  • He Z; Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.
  • Wang J; Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.
  • Sa R; Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.
  • Chen L; Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.
Front Genet ; 13: 966365, 2022.
Article in En | MEDLINE | ID: mdl-36437939
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Front Genet Year: 2022 Type: Article Affiliation country: China
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Front Genet Year: 2022 Type: Article Affiliation country: China